Nejatollahi et al., 2014 - Google Patents
Neutralizing human single-chain antibodies against Herpes Simplex Virus type 1 glycoprotein D from a phage display libraryNejatollahi et al., 2014
View PDF- Document ID
- 13404365128711824267
- Author
- Nejatollahi F
- Bagheri V
- Motamedifar M
- Moazen B
- Publication year
- Publication venue
- Int. J. Microbiol. Immunol. Res
External Links
Snippet
Among the 12 glycoproteins of the Herpes simplex virus type 1 envelope (HSV-1), glycoprotein D (gD) plays a critical role in the entry of the virus into target cells and cell-to- cell spread. gD is an attractive target for molecular intervention and monoclonal antibodies …
- 230000003472 neutralizing 0 title abstract description 24
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Krawczyk et al. | Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus | |
| US9657088B2 (en) | Anti-HSV antibody | |
| CN104955847A (en) | HIV-1 Env-binding antibodies, fusion proteins, and methods of use | |
| US11723977B2 (en) | Broadly neutralizing antibodies directed against the rabies virus glycoprotein and uses thereof | |
| WO2010010466A2 (en) | Neutralizing anti-influenza a virus antibodies and uses thereof | |
| CA2703667A1 (en) | Anti-rsv g protein antibodies | |
| US9017668B2 (en) | High affinity human antibodies to human cytomegalovirus (CMV) gB protein | |
| CN115515976A (en) | Coronavirus antibody | |
| Parsons et al. | Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH | |
| Jiang et al. | A single chain antibody fragment expressed in bacteria neutralizes tick-borne flaviviruses | |
| Tikunova et al. | The neutralizing human recombinant antibodies to pathogenic Orthopoxviruses derived from a phage display immune library | |
| Oldoni et al. | Production and characterization of monoclonal antibodies to a Brazilian bovine herpesvirus type 5 | |
| Nejatollahi et al. | Neutralizing human single-chain antibodies against Herpes Simplex Virus type 1 glycoprotein D from a phage display library | |
| Bagheri et al. | Neutralizing human recombinant antibodies against herpes simplex virus type 1 glycoproteins B from a phage-displayed scFv antibody library | |
| CN114456264B (en) | Novel human antibody of rare broad-spectrum epitope of coronavirus and application thereof | |
| Suzuki et al. | Isolation of therapeutic human monoclonal antibodies for varicella‐zoster virus and the effect of light chains on the neutralizing activity | |
| Koti et al. | Construction of single-chain Fv with two possible CDR3H conformations but similar inter-molecular forces that neutralize bovine herpesvirus 1 | |
| CN103755805B (en) | The specific human monoclonal antibodies of HIV-1 Env | |
| CN113980125B (en) | Neutralizing monoclonal antibody for resisting SFTSV and application thereof | |
| EP4174083A1 (en) | Neutralizing monoclonal antibodies against sarbecoviruses | |
| Molinková et al. | In vitro neutralization of equid herpesvirus 1 mediated by recombinant antibodies | |
| WO2020233715A1 (en) | Anti-hepatitis b virus antibodies and use thereof | |
| Geoghegan | Identification and Applications of Llama-Derived Single Domain Antibodies Binding to Glycoprotein D of Herpes Simplex Virus 2 | |
| Tao et al. | Recombinant human IgG antibodies against human cytomegalovirus | |
| IL300836A (en) | Anti–pox viruses antibodies |